GENE ONLINE|News &
Opinion
Blog

FDA Approval
Trials & Approvals Dry Eye
First Generic for Dry-eye Gets U.S. FDA Nod
2022-02-04
Trials & Approvals Schizophrenia
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
Trials & Approvals HIV
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Innovation COVID-19 Vaccine
Quebec-based Medicago Preps its Homegrown Plant-based COVID-19 Vaccine for Canada Approval, Touting Promising Phase 3 Data
2021-12-21
Trials & Approvals Myasthenia Gravis
argenx’s Novel Treatment for Myasthenia Gravis gets FDA Nod
2021-12-21
Innovation Alzheimer's Disease
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
Trials & Approvals Organ Transplant
Takeda’s Livtencity Bags FDA Approval for the Treatment of Post-Transplant Infection
2021-11-24
Trials & Approvals Cancer
FDA Approves Aadi Bioscience’s First Product to Treat Rare Cancer
2021-11-23
Trials & Approvals Dwarfism
BioMarin’s Dwarfism Drug Garners FDA Nod Amidst Concerns Over Threat to Dwarf Pride
2021-11-21
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Rare Disease
FDA Greenlights First and Only Treatment for Cholestatic Pruritus with ALGS
2021-10-04
Trials & Approvals CAR T-cell Therapy
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
Trials & Approvals
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
Trials & Approvals FDA Approval
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Trials & Approvals Schizophrenia
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
1 … 3 4 5 6 7 … 9
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top